RECRUITING

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

Talk to us

Conditions

Lung FibrosisLung Interstitial Disease

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this clinical trial is to determine the impact of a home-based pulmonary rehabilitation program with health coaching on patient-reported respiratory-related quality of life and physical activity, as compared to usual care in patients with fibrotic interstitial lung disease.

Official Title

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease: A Prospective Pragmatic Randomized Waitlist-Controlled Trial

Quick Facts

Study Start:2025-03-03
Study Completion:2030-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06751069

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * F-ILD diagnosis, any disease subtype, active or prior medical treatment
  2. * \>10% fibrosis on CT imaging
  3. * mMRC dyspnea score \>1
  4. * All racial or ethnic categories, including non-English speakers (professional translators will be engaged to support screening, enrollment, and study participation)
  1. * Inability to walk (orthopedic/neurologic/cardiac limitation causing immobility)
  2. * Cognitive impairment or inability to understand and follow instructions
  3. * Traditional center-based PR completed within 3 months of initial study recruitment
  4. * Transition to hospice or end-of-life care at the time of screening
  5. * Acute exacerbation at the time of screening

Contacts and Locations

Study Contact

Johanna Hoult, MS
CONTACT
507-293-1989
hoult.johanna@mayo.edu

Principal Investigator

Teng Moua
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Arizona
Scottsdale, Arizona, 85259
United States
Mayo Clinic in Florida
Jacksonville, Florida, 32224
United States
Mayo Clinic in Rochester
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Teng Moua, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-03
Study Completion Date2030-09-30

Study Record Updates

Study Start Date2025-03-03
Study Completion Date2030-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Fibrosis
  • Lung Interstitial Disease